Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

JP Morgan Analyst Upgrades Axon Enterprise to Overweight with 330 Price Target

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Finance_Fiscal (3)
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Analyst Paul Chung from JP Morgan has recently boosted Axon Enterprise (NASDAQ: AXON) to an Overweight rating and increased the price target to $330. This upgrade showcases a bullish view on the company’s potential growth and performance. As of February 28, 2024, Axon’s average one-year price target stands at $252.47, with predictions ranging from $225.23 to a high of $330. JP Morgan’s upgrade indicates a strong belief in Axon’s future outlook and financial success.

AXON Stock Shows Strong Performance with After-Hours Surge on February 28, 2024

On February 28, 2024, AXON stock demonstrated strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of AXON shares closed at $271.82, representing a $0.23 increase since the market last closed, a 0.08% rise.

Following the market close, AXON stock continued to show positive momentum in after-hours trading, with the stock price rising by $11.18. This significant increase further indicates the bullish sentiment surrounding AXON and suggests that investors are optimistic about the company’s future prospects.

AXON Stock Analysis: Strong Revenue Growth but Decrease in EPS Raises Concerns

On February 28, 2024, AXON stock showed strong performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.56 billion for the past year, which represents a significant increase of 31.38% compared to the previous year. Additionally, the total revenue for the fourth quarter of the year was $432.14 million, showing a 4.48% increase compared to the previous quarter.

In terms of net income, AXON reported a net income of $174.23 million for the past year, reflecting an 18.41% increase compared to the previous year. However, the net income for the fourth quarter was $57.27 million, which remained flat compared to the previous quarter.

Earnings per share (EPS) for AXON were $2.31 for the past year, showing a 13.87% increase compared to the previous year. However, the EPS for the fourth quarter was $0.75, representing a 4.09% decrease compared to the previous quarter.

Overall, AXON stock showed positive growth in terms of total revenue and net income compared to the previous year. However, the decrease in EPS for the fourth quarter may have caused some concern among investors. It will be interesting to see how AXON continues to perform in the upcoming quarters and whether they can sustain their growth trajectory. Investors should closely monitor the company’s financial reports and market performance to make informed decisions regarding their investments in AXON stock.

Tags: AXON
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Revolutionary Weight Loss Implants by Vivani Medical A GameChanger in Obesity Treatment

Finance_Investment (2)

Analyst Upgrades Carlyle Secured Lending to Neutral Rating and Raises Price Target

Telecommunications Industry Stock Exchange

Globalstar Reports Strong Sales Growth and Positive Outlook for Fiscal Year 2024

Recommended

Alx Oncology Holdings  Stock

Pivotal Week Ahead for Alx Oncology Investors

5 days ago
Rheinmetall Stock

Rheinmetall’s Naval Ambitions Signal Major Strategic Shift

2 months ago
Solar panel

Biden Administration Temporarily Halts Approval of LNG Exports to Assess Environmental and Energy Impacts

2 years ago
Synopsys Stock

Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings

2 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Norfolk Southern at a Crossroads: Investors Divided Over Future Direction

Avnet Shares Face Critical Test Amid Margin Pressures

Pfizer’s High-Stakes Bid for Weight-Loss Drug Maker Intensifies

Devon Energy Stock: Strong Quarterly Results Fuel Optimism

MannKind Shares Surge on Exceptional Quarterly Performance

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

Trending

Lululemon Stock
Analysis

Lululemon’s Growth Engine Stalls: Can the Athleisure Giant Regain Its Footing?

by Robert Sasse
November 6, 2025
0

The athleisure sector's former darling now confronts the most severe challenge in its corporate history. Lululemon faces...

Nike Stock

Nike Shares Face Sustained Decline as Investor Confidence Wanes

November 6, 2025
Digital Turbine Stock

Digital Turbine Shares Surge on Exceptional Quarterly Performance

November 6, 2025
Norfolk Southern Stock

Norfolk Southern at a Crossroads: Investors Divided Over Future Direction

November 6, 2025
Avnet Stock

Avnet Shares Face Critical Test Amid Margin Pressures

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lululemon’s Growth Engine Stalls: Can the Athleisure Giant Regain Its Footing?
  • Nike Shares Face Sustained Decline as Investor Confidence Wanes
  • Digital Turbine Shares Surge on Exceptional Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com